Background: Identifying transcatheter aortic valve replacement (TAVR) patients at high risk
for cerebrovascular events (CVE) is of major clinical relevance. However, predictors have …

Transcatheter aortic valve replacement (TAVR) has become a safe and effective therapy for
patients with severe aortic stenosis (AS). In recent trials, the hemodynamic performance and …

Background Previous trials have shown that among high-risk patients with aortic stenosis,
survival rates are similar with transcatheter aortic-valve replacement (TAVR) and surgical …

Background Transcatheter aortic valve replacement (TAVR) with the SAPIEN 3 valve
demonstrates good 30 day clinical outcomes in patients with severe aortic stenosis who are …

Background: Neurological complications after transcatheter aortic valve replacement (TAVR)
may be reduced with transcatheter cerebral embolic protection (TCEP). Objectives: This …

Background: There are limited data on the incidence, clinical implications, and predisposing
factors of transcatheter heart valve (THV) thrombosis following transcatheter aortic valve …

Aims: Our aim was to determine whether use of the filter-based Sentinel™ Cerebral
Protection System (CPS) during transcatheter aortic valve implantation (TAVI) can affect the …

Background—Prior studies of stroke and transient ischemic attack (TIA) after transcatheter
aortic valve replacement (TAVR) are limited by reporting and follow-up variability. This is a …

Background: The use of a balloon-expandable transcatheter heart valve previously resulted
in a greater rate of device success compared with a self-expandable transcatheter heart …

Objectives: The aim of this study was to identify variables associated with tissue fragment
embolization during transcatheter aortic valve replacement (TAVR). Background: Brain …